Description
The European nitrile medical glove market exhibited a value of $2.34 billion in 2022 and is anticipated to reach $4.05 billion by 2029, reflecting a notable compound annual growth rate (CAGR) of 7.8%. Nitrile gloves, crafted from synthetic rubber, have emerged as a preferred alternative to latex gloves due to their exceptional puncture resistance and latex-free nature. These attributes make them highly suitable for individuals with latex sensitivities and allergies. The growing adoption of nitrile gloves among healthcare professionals (HCPs) can be attributed to their non-allergic properties, further driving their popularity.
To address concerns related to glove disposal, vendors have introduced biodegradable options, aligning with the increasing focus on sustainability. European countries are actively pursuing the development of domestic manufacturing capabilities in order to reduce reliance on Asian countries, which currently serve as the primary base for nitrile glove manufacturers with subsidiaries in Europe. This strategic approach aims to enhance self-sufficiency and mitigate supply chain vulnerabilities.
E-commerce channels have played a pivotal role in the nitrile medical glove market, particularly during the COVID-19 pandemic. These platforms have facilitated the seamless purchase and distribution of medical gloves, meeting the heightened demand from healthcare facilities and individuals alike. The convenience and accessibility offered by e-commerce have significantly contributed to the market's growth and are expected to continue driving its expansion in the foreseeable future.
Market Segmentation
The market is segmented based on various factors, including type, application, end user, and geography.
Segmentation by Type
Non-Powdered
Powdered
Segmentation by Application
Examination (By Powdered & Non-Powdered)
Surgical (By Powdered & Non-Powdered)
Segmentation by End-users
Hospitals
Diagnostic Laboratories
ASCs
Clinics
Others
Segmentation by Geography
Germany
France
UK
Italy
Spain
The demand for non-powdered nitrile medical gloves is rapidly increasing in Europe due to allergies associated with powdered latex gloves. End-users are shifting to nitrile gloves for their superior benefits. Manufacturers are introducing environmentally-friendly products to meet market demands. Hospitals are the dominant end-users, holding a 51.7% market share in 2022 and growing at a CAGR of 8.1%. Hospitals procure gloves directly from manufacturers or via Group Purchase Organizations (GPOs) for cost advantages. Although the number of hospitals is declining, the rise of alternative care platforms increases overall glove consumption.
Germany has the largest market share in the European nitrile medical glove market, accounting for 21.5% in 2022. Factors such as high healthcare standards, advanced facilities, growing elderly population, increased healthcare expenditure, and demand for safety devices contribute to the market's growth in Germany. The market in Germany is projected to grow at a CAGR of 8.2%.
Competitive Landscape
The European nitrile medical glove market is highly competitive. Key companies profiled in the report include A1 Globe Sdn Bhd, Adventa Health Sdn Bhd, Akzenta International SA, Ansell Limited, B. Braun Melsungen AG, Bergamot Sdn. Bhd., Cardinal Health Inc., Global Gloves S.R.L., Hartalega Holdings Bhd., Hycare International Co. Ltd., Intco Medical Technology Co. Ltd., Kanam Latex Industries Pvt. Ltd., Kossan Rubber Industries Bhd, Leboo Healthcare Products Limited, Molnlycke Health Care AB, Neomedic Pty Ltd., Phoenix Rubber Products Co. Ltd., Pidegree Industrial Co. Ltd., RFB Latex Ltd., Riverstone Holdings Limited, SAS O+ France (Alsace Protection), Semperit AG Holding, SORIMEX sp. z o.o. sp. k., Tan Sin Lian Industries Sdn Bhd, Top Glove Corporation Berhad.
Why Buy This Report?
Get a detailed picture of the Europe Nitrile Medical Glove Market
Identify segments/areas to invest in over the forecast period in the Europe Nitrile Medical Glove Market
Understand the competitive environment, the market's leading players
The market estimate for ease of analysis across scenarios in Excel format
Strategy consulting and research support for three months
Print authentication provided for the single-user license
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
PART 5. EUROPE NITRILE MEDICAL GLOVE MARKET BY TYPE
5.1 Non-powdered
5.2 Powdered
PART 6. EUROPE NITRILE MEDICAL GLOVE MARKET BY APPLICATION
6.1 Examination (powdered & non-powdered)
6.2 Surgical (powdered & non-powdered)
PART 7. EUROPE NITRILE MEDICAL GLOVE MARKET BY END USER
7.1 ASCs
7.2 Clinics
7.3 Diagnostic laboratories
7.4 Hospitals
7.5 Others
PART 8. EUROPE NITRILE MEDICAL GLOVE MARKET BY GEOGRAPHY
8.1 Germany
8.2 France
8.3 UK
8.4 Italy
8.5 Spain
PART 9. COMPANY PROFILES
9.1 A1 Globe Sdn Bhd
9.2 Adventa Health Sdn Bhd
9.3 Akzenta International SA
9.4 Ansell Limited
9.5 B. Braun Melsungen AG
9.6 Bergamot Sdn. Bhd.
9.7 Cardinal Health, Inc.
9.8 Global Gloves S.R.L.
9.9 Hartalega Holdings Bhd.
9.10 Hycare International Co., Ltd.
9.11 Intco Medical Technology Co., Ltd.
9.12 Kanam Latex Industries Pvt. Ltd.
9.13 Kossan Rubber Industries Bhd
9.14 Leboo Healthcare Products Limited
9.15 Molnlycke Health Care AB
9.16 Neomedic Pty Ltd.
9.17 Phoenix Rubber Products Co., Ltd.
9.18 Pidegree Industrial Co., Ltd.
9.19 RFB Latex Ltd.
9.20 Riverstone Holdings Limited
9.21 SAS O+ France (Alsace Protection)
9.22 Semperit AG Holding
9.23 SORIMEX sp. z o.o. sp. k.
9.24 Tan Sin Lian Industries Sdn Bhd
9.25 Top Glove Corporation Berhad
DISCLAIMER